Literature DB >> 8070089

ELISA of pentosidine, an advanced glycation end product, in biological specimens.

S Taneda1, V M Monnier.   

Abstract

Pentosidine is a fluorescent protein cross-link and glycoxidation marker for the advanced glycation reaction in diabetes, aging, and uremia. We raised polyclonal antibodies in New Zealand White rabbits against this hapten coupled to keyhole limpet hemocyanin. The antibodies detected by ELISA reacted strongly with free pentosidine but not with pentosidine-like compounds. The working range of the competitive ELISA for standard pentosidine was 0.1-100 pmol. Pentosidine was detectable in bovine serum albumin incubated with ribose as a function of incubation time. Immunoblotting studies showed that pentosidine specifically stained in oligomers of lysozyme incubated with ribose. Digestion with protease (Pronase E, 20 g/kg) as well as acid hydrolysis enhanced the immunoreactivity of samples, the pentosidine values in digested human plasma correlating with those measured by HPLC (r = 0.98). Pentosidine in diabetic and uremic plasma digested with Pronase E was significantly higher than normal (P < 0.01; mean +/- SD): 1620 +/- 1940 and 2630 +/- 1320 [corrected] nmol/L, respectively, vs 151 +/- 55 nmol/L (normal). Amounts of pentosidine in hydrolyzed skin collagen increased with age and were increased in diabetes and uremia. This ELISA provides a new tool for assessing the role of the advanced Maillard reaction in aging and age-related diseases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8070089

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  17 in total

Review 1.  Normal and pathologic concentrations of uremic toxins.

Authors:  Flore Duranton; Gerald Cohen; Rita De Smet; Mariano Rodriguez; Joachim Jankowski; Raymond Vanholder; Angel Argiles
Journal:  J Am Soc Nephrol       Date:  2012-05-24       Impact factor: 10.121

Review 2.  Role of the Maillard reaction in diabetes mellitus and diseases of aging.

Authors:  S R Thorpe; J W Baynes
Journal:  Drugs Aging       Date:  1996-08       Impact factor: 3.923

Review 3.  Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms.

Authors:  Alin Stirban; Thomas Gawlowski; Michael Roden
Journal:  Mol Metab       Date:  2013-12-07       Impact factor: 7.422

4.  Unexpected crosslinking and diglycation as advanced glycation end-products from glyoxal.

Authors:  Andrea F Lopez-Clavijo; Carlos A Duque-Daza; Andrew Soulby; Isolda Romero Canelon; Mark Barrow; Peter B O'Connor
Journal:  J Am Soc Mass Spectrom       Date:  2014-10-15       Impact factor: 3.109

5.  Collagen: quantification, biomechanics, and role of minor subtypes in cartilage.

Authors:  Benjamin J Bielajew; Jerry C Hu; Kyriacos A Athanasiou
Journal:  Nat Rev Mater       Date:  2020-07-20       Impact factor: 66.308

Review 6.  An overview of in vitro and in vivo glycation of albumin: a potential disease marker in diabetes mellitus.

Authors:  Km Neelofar; Jamal Ahmad
Journal:  Glycoconj J       Date:  2017-08-15       Impact factor: 2.916

7.  Formation of Pentosidine Cross-Linking in Myoglobin by Glyoxal: Detection of Fluorescent Advanced Glycation End Product.

Authors:  Sauradipta Banerjee
Journal:  J Fluoresc       Date:  2017-03-15       Impact factor: 2.217

8.  The association of urinary pentosidine levels with the prevalence of osteoporotic fractures in postmenopausal women.

Authors:  Masataka Shiraki; Shoji Kashiwabara; Takumi Imai; Shiro Tanaka; Mitsuru Saito
Journal:  J Bone Miner Metab       Date:  2019-06-18       Impact factor: 2.626

Review 9.  Review: Glycation of human serum albumin.

Authors:  Jeanethe Anguizola; Ryan Matsuda; Omar S Barnaby; K S Hoy; Chunling Wa; Erin DeBolt; Michelle Koke; David S Hage
Journal:  Clin Chim Acta       Date:  2013-07-24       Impact factor: 3.786

10.  Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis.

Authors:  T Miyata; S Taneda; R Kawai; Y Ueda; S Horiuchi; M Hara; K Maeda; V M Monnier
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.